MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Delcath Systems ROE Ratio 2011-2026 | DCTH
Annual ROE Ratio Delcath Systems
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -38.38 | -302.2 | 623.11 | -214.6 | -109.41 | 139.67 | 128.67 | -6654.42 | 1206.11 | -170.96 | -95.79 | -100.75 | -259.22 | -118.35 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1206.11 | -6654.42 | -426.18 |
Quarterly ROE Ratio Delcath Systems
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26.37 | 47.4 | -282.96 | -382.04 | -464.33 | -568.36 | 2735.46 | 2962.58 | 3131.79 | 3383.29 | 764.21 | 353.92 | 293.16 | 63.18 | -336.19 | -136.9 | -159.51 | -121.35 | -98.3 | -77.57 | 40.7 | 181.59 | 294.69 | 336.2 | 395.64 | 336.8 | 287.63 | 55.91 | -2782.73 | -4699.99 | -5031.13 | -6654.42 | -3246.25 | -1321.05 | -587.02 | 1206.04 | 577.27 | 481.73 | -8.73 | -170.96 | -127.95 | -124.91 | -107.25 | -95.79 | -95.48 | -94.3 | -87.16 | -100.75 | -138.09 | -173.19 | -227.5 | -259.24 | -264.47 | -237.26 | -185.64 | -118.31 | -31.83 | -20.91 | -7.08 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3383.29 | -6654.42 | -197.82 |
ROE Ratio of other stocks in the Medical devices industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
-9.59 | $ 33.35 | 2.25 % | $ 1.48 B |  USA |
 |
Allied Healthcare Products
AHPI
|
-36.97 | - | 3.58 % | $ 2.21 M | USA |
 |
Apollo Endosurgery
APEN
|
-122.23 | - | - | $ 475 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-19.79 | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-10.47 | - | - | $ 3.31 B | USA |
 |
Acutus Medical
AFIB
|
9290.44 | - | -26.83 % | $ 2.62 M | USA |
 |
Lianluo Smart Limited
LLIT
|
-115.26 | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
-264.39 | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
97.55 | - | 1.37 % | $ 20.5 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-6.08 | $ 7.09 | 3.2 % | $ 509 M |  Israel |
 |
Apyx Medical Corporation
APYX
|
-70.08 | $ 3.85 | 0.79 % | $ 133 M | USA |
 |
Alphatec Holdings
ATEC
|
1144.21 | $ 13.41 | 2.33 % | $ 1.92 B | USA |
 |
BIOLASE
BIOL
|
8353.04 | - | -13.19 % | $ 166 K | USA |
 |
Bio-Rad Laboratories
BIO
|
-10.9 | $ 259.84 | -10.91 % | $ 7.33 B | USA |
 |
Conformis
CFMS
|
-93.16 | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
6.35 | $ 36.2 | -3.51 % | $ 5.39 K | USA |
 |
BioSig Technologies
BSGM
|
669.04 | - | 37.08 % | $ 85.7 M | USA |
 |
CONMED Corporation
CNMD
|
13.76 | $ 42.01 | 0.74 % | $ 1.3 B | USA |
 |
Boston Scientific Corporation
BSX
|
8.48 | $ 75.35 | 1.66 % | $ 111 B | USA |
 |
Abbott Laboratories
ABT
|
28.12 | $ 112.29 | 0.73 % | $ 195 B | USA |
 |
Cardiovascular Systems
CSII
|
-14.8 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
33.31 | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
-5.07 | - | -4.14 % | $ 702 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-46.5 | $ 4.79 | 0.42 % | $ 179 M |  France |
 |
ClearPoint Neuro
CLPT
|
-74.5 | $ 13.81 | 5.9 % | $ 373 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-910.25 | - | 1.15 % | $ 34.5 M | USA |
 |
Electromed
ELMD
|
17.44 | $ 23.82 | 2.21 % | $ 201 M | USA |
 |
Soliton, Inc.
SOLY
|
-46.94 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-0.13 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-25.4 | - | 0.03 % | $ 1.58 B | Israel |
 |
Dynatronics Corporation
DYNT
|
-334.18 | - | 14.99 % | $ 929 K | USA |
 |
Misonix, Inc.
MSON
|
-11.88 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-1451.06 | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
-107.92 | - | - | $ 955 M | USA |
 |
Eargo
EAR
|
-156.15 | - | - | $ 10.2 M | USA |
 |
Inogen
INGN
|
-20.64 | $ 5.88 | 1.52 % | $ 139 M | USA |
 |
InMode Ltd.
INMD
|
25.76 | $ 14.32 | 0.14 % | $ 1.14 B | Israel |
 |
GBS
GBS
|
-352.75 | - | -0.57 % | $ 7.12 M | USA |
 |
IRadimed Corporation
IRMD
|
22.15 | $ 101.26 | 1.42 % | $ 1.28 B | USA |
 |
Integer Holdings Corporation
ITGR
|
7.4 | $ 85.84 | 0.68 % | $ 2.88 B | USA |
 |
Second Sight Medical Products
EYES
|
-133.37 | - | -0.97 % | $ 54.4 M | USA |
 |
Penumbra
PEN
|
1.22 | $ 340.3 | 0.46 % | $ 13.1 B | USA |
 |
Avinger
AVGR
|
295.39 | - | -20.74 % | $ 369 K | USA |
 |
FONAR Corporation
FONR
|
8.28 | $ 18.54 | - | $ 122 M | USA |
 |
Globus Medical
GMED
|
2.47 | $ 89.17 | 2.24 % | $ 12.1 B | USA |
 |
Pulmonx Corporation
LUNG
|
-65.72 | $ 1.49 | 4.93 % | $ 58.3 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
-0.45 | $ 11.52 | 6.57 % | $ 887 M | USA |
 |
Myomo
MYO
|
-168.59 | $ 0.81 | 1.15 % | $ 5.71 M | USA |
 |
Establishment Labs Holdings
ESTA
|
-159.33 | $ 72.85 | -0.94 % | $ 2.05 B |  Costa-rica |